Executive record

Jason A. Okazaki

Director at ASSEMBLY BIOSCIENCES, INC.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:jason-a-okazakiVersion: public-0As of: 2026-09-30

Not yet claimed10 published Claims4 sources
  • Director

Key Claims

Biography

Mr. Okazaki has served as Chief Executive Officer and President of Assembly Biosciences since January 2023. He previously served as President and Chief Operating Officer, and Chief Operating Officer. He served in positions of increasing responsibility in Gilead's legal department from 2006 until March 2020, culminating as Senior Vice President, Legal. He has significant experience in strategic transactions, corporate governance, and business operations.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Named Executive Officer · Organization not publishedASMB DEF 14A executive officers
  2. Dates not publishedExecutive title: Chief Executive Officer and President · Organization not publishedASMB DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ASMB DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Assembly Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Executive Officer and President · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. ASMB DEF 14A executive officers

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Assembly Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Named Executive Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  3. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at ASSEMBLY BIOSCIENCES, INC. · Claim reviewed: May 15, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ASSEMBLY BIOSCIENCES, INC. · Claim reviewed: May 15, 2026